"Target therapy", "biologics" and "immunotherapy" are currently the new mainstreams in the field of clinical pharmacology. They are wildly used in the treatment of ocular diseases. However, systemic use of these drugs may also lead to ocular complications. In this article, the basic concept of these drugs and their role in ophthalmic filed was discussed.
為了持續優化網站功能與使用者體驗,本網站將Cookies分析技術用於網站營運、分析和個人化服務之目的。
若您繼續瀏覽本網站,即表示您同意本網站使用Cookies。